Ajugamarin H 1 exhibits significant anti-inflammatory activity, making it a candidate for development in treatments targeting inflammatory diseases. It has been shown to inhibit key pro-inflammatory mediators such as nitric oxide (NO) and prostaglandin E2 (PGE2) in cellular models, suggesting potential use in reducing chronic inflammation. Additionally, it demonstrates moderate antioxidant properties, which may contribute to its protective effects in oxidative stress-related conditions. Research also indicates possible neuroprotective applications due to its ability to cross biological barriers and modulate signaling pathways involved in neuronal survival. While still in early-stage investigation, its natural origin and bioactivity profile support further exploration for therapeutic use in inflammatory and neurodegenerative disorders.